Urinary EGF/Creatinine Ratio as a Biomarker for CKD Progression and SGLT2i Effects

New multicenter analyses confirm urinary EGF/creatinine (uEGF/Cr) ratio as an independent marker of tubular health and kidney risk in CKD populations with and without type 2 diabetes. SGLT2 inhibitors attenuate uEGF/Cr decline, providing prognostic value beyond albuminuria.

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.